EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Identification of novel protein biomarkers and therapeutic targets for ankylosing spondylitis using human circulating plasma proteomics and genome analysis

Zhongxian Zhou, Chong Liu, Sitan Feng, Jiarui Chen, Tianyou Chen, Jichong Zhu, Shaofeng Wu, Chenxing Zhou, Chengqian Huang, Jiang Xue, Xiaopeng Qin, Xinli Zhan

Analytical and Bioanalytical Chemistry · 2024-11 · 416 (28) · 6357-6366

DOI: 10.1007/s00216-024-05521-4 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Analytical and Bioanalytical Chemistry, online erschienen am 10.09.2024. Verfasst von Zhongxian Zhou und 11 weiteren Autor:innen. Beteiligte Einrichtung: Spine Surgery, The First Affiliated Hospital of Guangxi Medical University, No. 6 Shuangyong Road, Qingxiu District, Nanning, 530021, Guangxi, People…. Hauptthemen laut MEDLINE: Spondylitis, Ankylosing, Proteomics, Biomarkers. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the National Natural Science Foundation of China, Guangxi Young and Middle aged Teacher's Basic Ability Promoting Project, Joint Project on Regional High-Incidence Diseases Research of Guangxi Natural Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The proteome serves as the primary basis for identifying targets for treatment. This study conducted proteomic range two-sample Mendelian randomization (MR) analysis to pinpoint potential protein markers and treatment targets for ankylosing spondylitis (AS). A total of 4907 data points on circulating protein expression were collected from a large-scale protein quantitative trait locus investigation involving 35,559 individuals. Using data from a Finnish study on AS as the outcome, the dataset comprised 166,144 individuals of European ancestry (1462 cases and 164,682 controls), and causal relationships were determined through bidirectional Mendelian randomization of two samples. Proteins were further validated and identified through single-cell expression analysis, certain cells showing enriched expression levels were detected, and possible treatment targets were optimized. Increased HERC5 expression predicted by genes was related to increased AS risk, whereas the expression of the remaining five circulating proteins, AIF1, CREB3L4, MLN, MRPL55, and SPAG11B, was negatively correlated with AS risk. For each increase in gene-predicted protein levels, the ORs of AS were 2.11 (95% CI 1.44–3.09) for HERC5, 0.14 (95% CI 0.05–0.41) for AIF1, 0.48 (95% CI 0.34–0.68) for CREB3L4, 0.54 (95% CI 0.42–0.68) for MLN, 0.23 (95% CI 0.13–0.38) for MRPL55, and 0.26 (95% CI 0.17–0.39) for SPAG11B. The hypothesis of a reverse causal relationship between these six circulating proteins and AS is not supported. Three of the six protein-coding genes were expressed in both the AS and healthy control groups, while CREB3L4, MLN, and SPAG11B were not detected. Increased levels of HERC5 predicted by genes are related to increased AS risk, whereas the levels of the remaining five circulating proteins, AIF1, CREB3L4, MLN, MRPL55, and SPAG11B, negatively correlate with AS risk. HERC5, AIF1, and MRPL55 are potential therapeutic targets for AS. This study advanced the field by employing a novel combination of proteomic range two-sample MR analysis and single-cell expression analysis to identify potential protein markers and therapeutic targets for AS. This approach enabled a comprehensive understanding of the causal relationships between circulating proteins and AS, which has not been extensively explored in previous studies. Graphical Abstract

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Spondylitis, AnkylosingProteomicsBiomarkersHumansMendelian Randomization AnalysisMaleFemaleQuantitative Trait LociBlood Proteins

Stichwörter der Autor:innen

Ankylosing spondylitisMendelian randomizationNovel protein biomarkersscRNA-seq

Substanzen

BiomarkersBlood Proteins

Autor:innen und Institutionen

  • Spine Surgery, The First Affiliated Hospital of Guangxi Medical University, No. 6 Shuangyong Road, Qingxiu District, Nanning, 530021, Guangxi, People's Republic of China.
  • Spine Surgery, The First Affiliated Hospital of Guangxi Medical University, No. 6 Shuangyong Road, Qingxiu District, Nanning, 530021, Guangxi, People's Republic of China. zhanxinli@stu.gxmu.edu.cn.

Förderung

  • the National Natural Science Foundation of China
  • Guangxi Young and Middle aged Teacher's Basic Ability Promoting Project
  • Joint Project on Regional High-Incidence Diseases Research of Guangxi Natural Science Foundation
  • Clinical Research Climbing Plan Project of the First Affiliated Hospital of Guangxi Medical University in 2023
  • Guangxi Young and Middle aged Teacher’s Basic Ability Promoting Project
  • Bethune Charity Foundation's "Constant Learning and Improvement-Medical Research" project
  • The “Medical Excellence Award” Funded by the Creative Research Development Grant from the First Affiliated Hospital of Guangxi Medical University

Zitieren

APA

Zhou, Z., Liu, C., Feng, S., Chen, J., Chen, T., Zhu, J., Wu, S., Zhou, C., Huang, C., Xue, J., Qin, X., & Zhan, X. (2024). Identification of novel protein biomarkers and therapeutic targets for ankylosing spondylitis using human circulating plasma proteomics and genome analysis. Analytical and Bioanalytical Chemistry, 416(28), 6357-6366. https://doi.org/10.1007/s00216-024-05521-4

Vancouver

Zhou Z, Liu C, Feng S, Chen J, Chen T, Zhu J, et al. Identification of novel protein biomarkers and therapeutic targets for ankylosing spondylitis using human circulating plasma proteomics and genome analysis. Analytical and Bioanalytical Chemistry. 2024;416(28):6357-6366. doi:10.1007/s00216-024-05521-4

BibTeX
@article{Zhou2024,
  author = {Zhou, Zhongxian and Liu, Chong and Feng, Sitan and Chen, Jiarui and Chen, Tianyou and Zhu, Jichong and Wu, Shaofeng and Zhou, Chenxing and Huang, Chengqian and Xue, Jiang and Qin, Xiaopeng and Zhan, Xinli},
  title = {Identification of novel protein biomarkers and therapeutic targets for ankylosing spondylitis using human circulating plasma proteomics and genome analysis},
  journal = {Analytical and Bioanalytical Chemistry},
  year = {2024},
  volume = {416},
  number = {28},
  pages = {6357--6366},
  doi = {10.1007/s00216-024-05521-4}
}
Kostenlos starten →